Young infants hospitalized with respiratory syncytial virus (RSV) often become much sicker than those infected with SARS-CoV-2, the virus that causes COVID-19. In a study published in Science ...

Since the start of the COVID-19 pandemic, there has been controversy surrounding the origins of SARS-CoV-2. New research from the University of California, San Diego (UCSD), School of Medicine ...

Sars is intensifying its efforts to recover R135 billion in outstanding tax debt, despite facing challenges with struggling ...

SARS intensifies efforts to regulate and tax social media influencers as the digital market grows, urging content creators to declare earnings for tax collection.

Those differences might explain why these two diseases have different clinical outcomes and require different treatment strategies. During the COVID-19 pandemic, physicians observed that infants ...

"We showed, for the first time, that two similar respiratory viruses, RSV and SARS-CoV-2, cause very different types of immune dysregulation in young infants," said co-corresponding author Octavio ...

(L) co-corresponding author Octavio Ramilo, MD, St. Jude Department of Infectious Diseases chair and (R) co-first author Asunción Mejías, MD, PhD, MsCS, St. Jude Department of Infectious Diseases.